Currently, retatrutide is in phase 3 clinical trials to get FDA approval
However, ongoing safety monitoring on Hers depends on patient-initiated check-ins rather than mandatory follow-up labs or clinical assessments, which may delay detection of dose-related complications or emerging health concerns
(21) Participants had an average age of 63 (SD: 5.5, range 40-85 years) and an average BMI of 27.5 (SD: 4.5), consisting of 55 postmenopausal women and 9 men
That's when I heard about Semaglutide, a weight loss medication that seemed to be getting some serious buzz
Due to their similar mechanisms of action, many of these side effects are similar across all three medications
Become a valued research partner with us, please feel free to contact us at [email protected]